Organization (Academic)
Medical University of Sofia
ClinicalTrials.gov lists Medical University of Sofia as lead sponsor of 10 trials. It has 13 active development programs and 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Medical University of Sofia, via Wikimedia Commons, CC0. Shown to identify the organization; it may be a registered trademark.
This page covers Medical University of Sofia: 10 lead-sponsored trials and 1 legal-entity registration.
Disease areas (24)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Periodontitis | 3 |
| Graves Disease | 2 |
| Graves Ophthalmopathy | 2 |
| Hyperthyroidism | 2 |
| Alveolar Bone Loss | 1 |
Showing 5 of 24 disease areas.
Trials by start year as sponsor or collaborator (7)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 3 |
| 2023 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2017 | 2 |
| 2016 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (13)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Emdogain | Furcation Defects | Not reported | 1 |
| Bio-Oss Collagen + Emdogain | Bone Resorption | Not reported | 1 |
| Bio-Oss Collagen + Emdogain | Periodontitis | Not reported | 1 |
| Bio-Oss Collagen + Emdogain | Alveolar Bone Loss | Not reported | 1 |
| Emdogain | Periodontitis | Not reported | 1 |
Showing 5 of 13 active programs.
Approved assets (1)
| Drug | Trials |
|---|---|
| METHYLPREDNISOLONE | 1 |
Journals published in (17)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Archives of women's mental health | 2 |
| International ophthalmology | 2 |
| Journal of women's health (2002) | 2 |
| Spine | 2 |
| Archives of internal medicine | 1 |
Showing 5 of 17 journals.
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Sirma Company | Co sponsors trial with | 1 |
| University Hospital for Active Treatment in Endocrinology "Acad Ivan Penchev" EAD | Co sponsors trial with | 1 |
Latest dated events (12)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-10-23 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-04-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-05-14 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-03-12 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 12 events.
Biomarker capability evidence (3)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| AGXT | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted (ClinVar) |
| NF1 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted (ClinVar) |
| NPHP3 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted (ClinVar) |
Biomarkers this organization publishes on (209)
Shown in this order: most publications first.
Showing 5 of 209 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.